Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 125 of 126 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/01/18
End: 06/30/20
Due: 06/30/21
Phase: N/A
Priority: Normal
Start: 11/01/17
End: 11/30/18
Due: 11/30/19
Phase: N/A
Priority: Normal
Start: 06/23/17
End: 11/01/19
Due: 11/01/20
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 02/28/17
Due: 02/28/18
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 03/31/08
Due: 03/31/09
Phase: N/A
Priority: Normal
Start: 12/09/20
End: 04/09/21
Due: 04/09/22
Phase: N/A
Priority: Normal
Start: 11/15/20
End: 11/05/26
Due: 11/05/27
Phase: N/A
Priority: Normal
Start: 04/11/18
End: 08/25/24
Due: 08/25/25
Phase: N/A
Priority: Normal
Start: 06/20/24
End: 04/30/28
Due: 04/30/29
Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase
Phase: N/A
Priority: Normal
Start: 12/31/00
End: 10/31/02
Due: 10/31/03
Phase: N/A
Priority: Normal
Start: 04/03/24
End: 05/05/24
Due: 05/05/25
Phase: N/A
Priority: Normal
Start: 02/05/18
End: 11/16/20
Due: 11/16/21
Phase: N/A
Priority: Normal
Start: 06/01/25
End: 05/30/29
Due: 05/30/30
Phase: N/A
Priority: Normal
Start: 12/31/16
End: 03/31/21
Due: 03/31/22
Phase: N/A
Priority: Normal
Start: 07/08/19
End: 11/30/19
Due: 11/30/20
Phase: N/A
Priority: Normal
Start: 10/30/24
End: 02/28/26
Due: 02/28/27
Phase: N/A
Priority: Normal
Start: 08/01/14
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: 08/01/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 08/31/13
End: 11/30/16
Due: 11/30/17
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 02/26/20
Due: 02/26/21
Phase: N/A
Priority: Normal
Start: 12/31/11
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 03/08/17
End: 01/10/19
Due: 01/10/20
Phase: N/A
Priority: Normal
Start: 04/03/23
End: 11/01/23
Due: 11/01/24
Phase: N/A
Priority: Normal
Start: 03/01/20
End: 10/31/21
Due: 10/31/22